facebook

What Is Dropped Nucleus and Why Does It Happen After PCR?

1 min read

A “dropped nucleus” means fragments of the cataract (lens material) fall through a posterior capsule tear into the vitreous cavity at the back of the eye. This occurs when PCR happens before the lens material has been fully removed, especially in dense cataracts where large fragments remain ¹.

The posterior capsule normally acts as a floor. When it tears, gravity and fluid currents can carry lens pieces backward. This does not mean the surgeon “lost control”; it reflects an anatomical barrier failure during a dynamic, fluid-based procedure.

Why it matters:

  • Lens fragments in the vitreous can provoke significant inflammation
  • They can raise intraocular pressure
  • They increase the risk of cystoid macular oedema and, rarely, retinal detachment

Management depends on fragment size and inflammation. Small fragments may be observed with intensive anti-inflammatory treatment. Larger or symptomatic fragments usually require pars plana vitrectomy by a vitreoretinal surgeon to remove the retained lens material ¹ ³.

Timing is tailored. Early surgery can reduce inflammation, but operating through a cloudy cornea can increase risk. Evidence suggests outcomes are good with timely vitrectomy, and brief delays to improve visibility may be clinically sensible ².

The goal is to restore a quiet eye and protect the retina.

References

  1. Kim JE, Flynn HW Jr, Smiddy WE, Murray TG, Rubsamen PE. Retained lens fragments after phacoemulsification. Ophthalmology. 1994;101(11):1827-1832.
  2. Scott IU, Flynn HW Jr, Dev S, Shaikh S, Mittra RA, Arevalo JF, Miller D. Functional and anatomic outcomes following vitreoretinal surgery for retained lens fragments. Ophthalmology. 2003;110(8):1567-1572.
  3. Vanner EA, Stewart MW. Vitrectomy timing for retained lens fragments after cataract surgery. Retina. 2011;31(8):1531-1538.

Related Topics

About Blue Fin Vision®

Blue Fin Vision® is a GMC-registered, consultant-led ophthalmology clinic with CQC-regulated facilities across London, Hertfordshire, and Essex. Patient outcomes are independently audited by the National Ophthalmology Database, confirming exceptionally low complication rates.